发明名称 1,5-benzothiazepines and their use as hypolipidaemics
摘要 The present invention relates to compounds of formula (I) wherein R<SUP>1 </SUP>and R<SUP>2 </SUP>are independently selected from C<SUB>1-6</SUB>alkyl; one of R<SUP>4 </SUP>and R<SUP>5 </SUP>is a group of formula (IA): R<SUP>3</SUP>, R<SUP>6</SUP>, R<SUP>7</SUP>, R<SUP>8</SUP>, R<SUP>9</SUP>, R<SUP>10 </SUP>and R<SUP>11 </SUP>and the other of R<SUP>4 </SUP>and R<SUP>5 </SUP>are as defined within, pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and there use as ileal bile acid transport (IBAT) inhibitors for the treatment of hyperlipidaemia. Processes for their manufacture and pharmaceutical compositions containing them are also described.
申请公布号 AU3755601(A) 申请公布日期 2001.09.17
申请号 AU20010037556 申请日期 2001.03.05
申请人 ASTRAZENECA AB 发明人 MICHAEL DAHLSTROM;DAVID BLOMBERG
分类号 A61K31/554;A61K45/00;A61P1/16;A61P3/06;A61P43/00;C07D281/10;C07D417/12;C07F9/6536 主分类号 A61K31/554
代理机构 代理人
主权项
地址